|
Dehydroepiandrosterone Effects on HIV-1 Replication Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Dehydroepiandrosterone Effects on HIV-1 Replication conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Dehydroepiandrosterone Effects on HIV-1 Replication Clinical research trials and Dehydroepiandrosterone Effects on HIV-1 Replication healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Dehydroepiandrosterone Effects on HIV-1 Replication. Dehydroepiandrosterone Effects on HIV-1 Replication Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Dehydroepiandrosterone Effects on HIV-1 Replication clinical trial. Subjects frequently obtain the most expert healthcare possible for their Dehydroepiandrosterone Effects on HIV-1 Replication condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Dehydroepiandrosterone Effects on HIV-1 Replication  Dehydroepiandrosterone Effects on HIV-1 Replication
Dehydroepiandrosterone Effects on HIV-1 Replication
For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Evidence of HIV-1 infection - HIV RNA <50 copies/mL - Stable antiretroviral treatment regimen for at least 8 weeks - Age 18 years or older - Normal pap smear and mammograph within 1 year (females) - Normal prostate-specific antigen level with in one year, age adjusted (males) Exclusion criteria: - Active opportunistic infections or malignancy other than localized cutaneous KS lesions - Concurrent or prior use within the past 8 weeks of DHA, testosterone, other anabolic steroids, corticosteroids, megestrol acetate, growth hormone, IL-2, or thalidomide - Diagnosis of AIDS Dementia Complex (stage II or higher) - Active substance abuse (e.g., alcohol or injection drugs) - Evidence of severe liver dysfunction or hepatic transaminases greater than 3x the upper normal limit - Pregnant or breast-feeding - History of endocrinologically-responsive tumors (e.g., breast, ovarian, uterine, or prostatic cancer, or malignant melanoma)
Total Enrollment: 40
Location and Contact Information:
Community Consortium
San Francisco, California, 94110
United States
Additional Information:
Study ID Numbers: 1 R01 AT00512-01; Abrams
Study Start Date: October 2000
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00065104
Other Hiv Infections Studies:
1. A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
2. Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
3. The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
4. Safety and Effectiveness of Combining Hydroxyurea (HU) with Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults
5. A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
Related Studies:
Other HIV Infections Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials
Dehydroepiandrosterone Effects on HIV-1 Replication
|
|
|
|
|
|
|
|
